Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities. Our technologies and pipeline include proprietary A-Kine™ biologics and Allo-Glue™ small molecule platforms with broad, innovative applications to the reprogramming of disease states. The company is currently advancing multiple novel immunotherapies for the treatment of cancer.
View Top Employees from Orionis Biosciences| Website | https://www.orionisbio.com |
| Revenue | $9.5 million |
| Funding | $55 million |
| Employees | 45 (35 on RocketReach) |
| Founded | 2015 |
| Address | 950 Winter St, Waltham, Massachusetts 02451, US |
| Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Health Diagnostics, Medical |
| Competitors | CALIXAR, Eurofins DiscoverX, Integral Molecular, JOINN Innovation Park, TetraGenetics Inc. |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Orionis Biosciences employee's phone or email?
Orionis Biosciences Questions
The Orionis Biosciences annual revenue was $9.5 million in 2024.
Robert Petit is the Senior Vice President, Head of Early Clinical Development of Orionis Biosciences.
35 people are employed at Orionis Biosciences.
Orionis Biosciences is based in Waltham, Massachusetts.
The NAICS codes for Orionis Biosciences are [54, 54171, 541714, 541, 5417].
The SIC codes for Orionis Biosciences are [87, 873].
Top Orionis Biosciences Employees
-
22
-
22
-
54
-
23
-
22
-
21
-
21
-
ViewJames Kyranos
Vice President, Technical Operations at Orionis Biosciences
Boston, Massachusetts, United States22
Related Companies
